User menu

Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors

Bibliographic reference Vantomme, V ; Dantinne, C ; Amrani, N ; Permanne, P. ; Gheysen, D. ; et. al. Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.Meeting of the Society-for-Biological-Therapy (SBT) (La Jolla(Ca), 2002). In: Journal Of Immunotherapy, Vol. 27, no. 2, p. 124-135 (2004)
Permanent URL http://hdl.handle.net/2078.1/61415